Company Filing History:
Years Active: 1997
Title: Innovations of Hideharu Sato
Introduction
Hideharu Sato is a notable inventor based in Toda, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the development of anti-inflammatory drugs. With a total of 2 patents, Sato's work has the potential to impact the treatment of various inflammatory diseases.
Latest Patents
Sato's latest patents include innovative compounds that show promise in medical applications. One of his patents focuses on 1-arylpyrimidine derivatives and their pharmaceutical uses. This invention relates to compounds represented by a specific general formula, where R1 can be hydrogen, alkyl, or aralkyl. Another significant patent involves purine derivatives that serve as suppressants for inflammatory diseases. These purine derivatives are designed to prevent tissue damage caused by mediators such as active oxygen and TXA2 during the initial stages of inflammation. They also aim to mitigate the aggravation of inflammatory responses by inhibiting the adhesion of activated leukocytes to affected cells.
Career Highlights
Hideharu Sato is currently associated with Japan Energy Corporation, where he continues to innovate in the pharmaceutical sector. His work is characterized by a strong focus on developing effective treatments for inflammatory conditions, showcasing his commitment to improving healthcare outcomes.
Collaborations
Sato collaborates with esteemed colleagues, including Yoshiaki Isobe and Yuso Goto. Their combined expertise enhances the research and development efforts within their organization.
Conclusion
Hideharu Sato's contributions to pharmaceutical innovations, particularly in anti-inflammatory treatments, highlight his role as a significant inventor in the field. His patents reflect a dedication to advancing medical science and improving patient care.